The Business Research Company's Medical High Pressure Syringe Global Market Report 2025 ... free injection device designed exclusively for insulin delivery - a significant leap in the diabetes ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

This technology replaces syringes and vials, or prefilled insulin pen needles. These wearable devices are filled with enough insulin to last 2 to 4 days, and through a small cannula inserted just ...

With type 2 diabetes, your body either doesn’t make enough insulin or doesn’t respond as usual to insulin. Your pancreas makes insulin. It’s a hormone that helps lower your blood sugar levels.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

Punjab Chief Minister Maryam Nawaz on Monday officially rolled out the “CM Insulin for Diabetes” initiative, a dedicated program aimed at supporting children suffering from type-I congenital ...